Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.62 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.62 |
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.62 |
| ▸ | NPC1 | O15118 | 1/20 | 0.62 |
| ▸ | RAB9A | P51151 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 4/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | GLA | P06280 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.58 |
| ▸ | MAOA | P21397 | 1/20 | 0.58 |
| ▸ | CASP1 | P29466 | 1/20 | 0.58 |
| ▸ | CASP7 | P55210 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29709713 | 1.00 | KMT2A (0.62) | KMT2ANPSR1SMN1; SMN2RXFP1MAPK1 | |
| SCHEMBL29416517 | 1.00 | KMT2A (0.62) | KMT2ANPSR1SMN1; SMN2RXFP1MAPK1 | |
| Water SCHEMBL28602073 | 0.98 | KMT2A (0.60) | KMT2ANPSR1SMN1; SMN2RXFP1MAPK1 | |
| SCHEMBL10025819 | 0.86 | L3MBTL1 (0.69) | KMT2ANPSR1SMN1; SMN2RXFP1MAPK1 | |
| SCHEMBL9787769 | 0.86 | MAOA (0.74) | KMT2ASMN1; SMN2MAPK1NPC1RAB9A | |
| SCHEMBL16802258 | 0.84 | SMN1; SMN2 (0.62) | KMT2ANPSR1SMN1; SMN2RXFP1MAPK1 | |
| SCHEMBL30966887 | 0.84 | ALDH1A1 (0.58) | KMT2ANPSR1SMN1; SMN2RXFP1MAPK1 | |
| SCHEMBL29391754 | 0.84 | ALDH1A1 (0.58) | KMT2ANPSR1SMN1; SMN2RXFP1MAPK1 | |
| SCHEMBL257 | 0.84 | ALDH1A1 (0.58) | KMT2ANPSR1SMN1; SMN2RXFP1MAPK1 | |
| SCHEMBL10025828 | 0.83 | L3MBTL1 (0.60) | KMT2ANPSR1SMN1; SMN2RXFP1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1343 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250276994-A1 | CAP ANALOG FOR THE 5'-END OF EUKARYOTIC MESSENGER RNAS | WESTFÄLISCHE WILHELMS-UNIVERSITÄT (DE) | 2025-09-04 | — | — | US | claimed |
| US-12227613-B2 | Photo-patternable organic semiconductor (OSC) polymers and methods of formation and applications thereof | CORNING INCORPORATED (US) | 2025-02-18 | — | — | US | claimed |
| CN-119119070-A | Organic compound with dibenzopyranone-like ring as core, preparation method and application thereof, and application of organic electroluminescent device | 烟台先进材料与绿色制造山东省实验室 | 2024-12-13 | — | — | CN | claimed |
| US-20240400503-A1 | NOVEL PHOTOINITIATORS | IGM RESINS ITALIA S.R.L. (IT) | 2024-12-05 | — | — | US | claimed |
| EP-4412990-A1 | NOVEL PHOTOINITIATORS | IGM Resins Italia S.r.l. (IT) | 2024-08-14 | — | — | EP | claimed |
| CN-118475556-A | Novel photoinitiators | 意大利艾坚蒙树脂有限公司 | 2024-08-09 | — | — | CN | claimed |
| CN-118420837-A | Decrosslinking modified elastomer regenerated material, and regeneration method and application thereof | 中山旺材科技有限公司 | 2024-08-02 | — | — | CN | claimed |
| CN-116178332-B | N-substituted benzocoumarin compound with breast cancer resisting activity and preparation method and application thereof | 新乡医学院 | 2024-05-24 | — | — | CN | claimed |
| EP-4367127-A1 | CAP ANALOG FOR THE 5'-END OF EUKARYOTIC MESSENGER RNAS | Westfälische Wilhelms-Universität Münster (DE) | 2024-05-15 | — | — | EP | claimed |
| CN-117865925-A | 3, 4-benzocoumarin compound based on complex functional aromatic hydrocarbon and preparation method and application thereof | 上海瑞苷生物科技有限公司 | 2024-04-12 | — | — | CN | claimed |
| EP-0710225-A1 | FLUORESCENCE DETERMINATION OF THE ACTIVITY OF LIPOLYTIC ENZYMES | PROGEN Biotechnik GmbH (DE) | 1996-05-08 | — | — | EP | claimed |
| WO-1995032181-A1 | FLUORESCENCE DETERMINATION OF THE ACTIVITY OF LIPOLYTIC ENZYMES | PROGEN BIOTECHNIK GMBH (DE) | 1995-11-30 | — | — | WO | claimed |
| US-5216146-A | 2-benzocoumarinyl-carbapenems | MERCK & CO., INC. (US) | 1993-06-01 | — | — | US | claimed |
| US-5182384-A | Chemical intermediates for bactericides | MERCK & CO., INC. (US) | 1993-01-26 | — | — | US | claimed |
| EP-0515232-A1 | 2-benzocoumarinyl-carbapenems | MERCK & CO. INC. (US) | 1992-11-25 | — | — | EP | claimed |
| EP-0515217-A1 | 2-Benzocoumarinyl carbapenems | MERCK & CO. INC. (US) | 1992-11-25 | — | — | EP | claimed |
| US-5162314-A | 2-benzocoumarinyl carbapenems | MERCK & CO., INC. (US) | 1992-11-10 | — | — | US | claimed |
| US-5104894-A | Ellagic acid analogues | UNIVERSITY OF GUELPH (CA) | 1992-04-14 | — | — | US | claimed |
| US-5073295-A | Coated with block copolymer of ethylene oxide and propylene oxide, ethoxylated stearyldiphenyloxyethyl diethylenetriamine; wear resistant, free-flowing, dustless | CIBA-GEIGY CORPORATION (US) | 1991-12-17 | — | — | US | claimed |
| US-4059702-A | ANTIVIRAL | RICHARDSON-MERRELL INC. (US) | 1977-11-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400503-A1 | NOVEL PHOTOINITIATORS | PPOX, CRY1, MAP1LC3A | KMT2A 283/4885NPSR1 3272/4885SMN1; SMN2 4821/4885 |
| US-20250276994-A1 | CAP ANALOG FOR THE 5'-END OF EUKARYOTIC MESSENGER RNAS | RNGTT, RNMT, NSUN2 | KMT2A 2792/4885NPSR1 3427/4885SMN1; SMN2 1778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.